Synfacts, Table of Contents

Synfacts 2024; 20(05): 0531
DOI: 10.1055/s-0043-1763722

Innovative Drug Discovery and Development

CVN766, the Selective Orexin-1-Receptor Antagonist Progressed to Clinical Investigations

(Roche), Contributor(s):

Antonia F. Stepan

,

Seong Heon Kim